Preventing Falls in Older Adults With Cognitive Frailty (ACTIVE)

September 3, 2026 updated by: Teresa Liu-Ambrose, University of British Columbia

ACTIVE: Adding Life to Years in Cognitive Frailty by Preventing Falls

The Problem: The proposed trial will address the problem of how to effectively prevent subsequent falls in community-dwelling cognitively frail older adults with a history of falls.

Primary Question: In community-dwelling older adults with cognitive frailty and a history of falls, can a home-based exercise program with behavioural change techniques significantly reduce falls vs. health education (i.e., control; CON)?

Study Overview

Detailed Description

Rationale: Falls are a significant cause of functional decline and often a sentinel event. Older adults with cognitive frailty - those with concurrent physical frailty and mild cognitive impairment - are at particular risk for falls. Notably, falls can cause a sudden and severe change in their health state from one of independence to one of dependence. Thus, effective falls prevention strategies need to be identified for older adults with cognitive frailty.

The Otago Exercise Program (OEP) - a physical therapist (PT) delivered home-based exercise program - is an evidence-based falls prevention program for community-dwelling older adults. Our pilot data show the OEP vs. usually care significantly reduced subsequent falls in 192 community-dwelling older adults with cognitive frailty and a history of falls; the incident rate ratio was 0.64 (95% CI, 0.43-0.98; P = .042). These preliminary findings need to be confirmed in a rigorously designed RCT powered for falls in older adults with cognitive frailty; none exist to date.

We also observed lower OEP adherence among older adults with cognitive frailty vs. those without cognitive frailty. Thus, strategies to support adherence must be considered in RCTs of exercise to prevent falls in this high-risk population. Evidence-based strategies include health coaching.

Thus, we propose a 12-month multi-site randomized controlled trial (RCT) in older adults with cognitive frailty and a history of falls to assess the efficacy of the OEP combined with health coaching (i.e., OEP+) to prevent falls.

Primary Question: In community-dwelling older adults with cognitive frailty and a history of falls, can the OEP+ significantly reduce falls vs. health education (i.e., control; CON)?

Secondary Questions: 1) What are additional benefits of the OEP+ vs. CON? 2) Do the benefits of OEP+ persist 6 months post cessation? 3) Can the OEP+ reduce falls or improve quality of life at similar or lower costs vs. CON?

Methods: A 12-month assessor-blinded, multi-site RCT, with a 6-month follow-up, in older adults, with cognitive frailty - defined by a Short Physical Performance Battery score <= 9/12 and a Montreal Cognitive Assessment score between 18-25/30 - and a history of falls. Participants will be randomized to either: a) OEP+ or b) CON. The OEP+ intervention will include Brief Action Planning-based health coaching. The CON group will include monthly interactive education sessions via Zoom. Measurement will occur at baseline, 6, 12, and 18 months, with falls tracked daily.

Study Type

Interventional

Enrollment (Estimated)

328

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • British Columbia
      • Vancouver, British Columbia, Canada, V5Z1M9
        • Recruiting
        • Centre for Aging SMART at VCH, University of BC

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

We will include individuals who meet the following criteria: 1) aged between 65 and 89 years; 2) live in Greater Vancouver, British Columbia; 3) are community-dwelling (i.e., not residing in a nursing home or extended care unit); 4) experienced a non-syncopal fall in the prior 12 months; 5) scored ≤ 9/12 on the SPPB; 6) have subjective cognitive impairment based on interview; 7) scored 18-25/30 on the MoCA [62,64]; 8) are able to walk with or without a gait aid; 9) scored ≥ 6/8 on Lawton and Brody Instrumental Activities of Daily Living Scale (IADL) [65]; 10) are able to safely engage in exercise as indicated by the Physical Activity Readiness Questionnaire for Everyone (PAR-Q+) [66]; and 11) are able to understand, speak, and read English with sufficient proficiency to complete the assessments.

*The age maximum of 89 was set due to the increased risk of significant adverse health outcomes cognitively frail older adults face. As this population has an increased risk of falls, functional disability with loss of independence, hospitalization, and death, setting an age maximum aims to increase the likelihood that participants will be able to complete the 18-month study without interruptions due to health complications. This age limit has been reviewed and approved by CIHR.

Exclusion Criteria:

We will exclude individuals who: 1) have been diagnosed with dementia, a neurodegenerative disease, or stroke; 2) report engaging in strength and balance training exercises ≥ 2 times per week in the prior 3 months; 3) have severe depression based on a score of ≥ 11/15 on the GDS.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Educational Control
All active control participants will be invited to join monthly interactive education sessions via Zoom or in-person.
All active comparator participants will be invited to join monthly interactive social and education sessions via Zoom or in-person (hybrid delivery).
Experimental: Otago Exercise Program (OEP) Plus
The OEP+ intervention integrates the OEP with health coaching by a physical therapist or kinesiologist. The OEP is an individualized home-based balance and strength exercise training program delivered by a PT or kinesiologist coach over 5 home visits and 6 phone check-ins
The OEP+ intervention integrates the OEP with health coaching by a physical therapists or kinesiologist. The OEP is an individualized home-based balance and strength exercise training program delivered by a PT or kinesiologist coach over 5 home visits.
Other Names:
  • Otago Exercise Program Plus (OEP+)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Falls
Time Frame: Daily tracking over 12 months
The number of self-reported falls during the 12-month intervention period (i.e., rate of falls).
Daily tracking over 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Short Physical Performance Battery
Time Frame: Baseline, 6 months, 12 months, 18 months
A physical performance battery out of 12 points (max. performance).
Baseline, 6 months, 12 months, 18 months
Montreal Cognitive Assessment
Time Frame: Baseline, 6 months, 12 months, 18 months
A test that covers multiple cognitive domains. Often used to screen for mild cognitive impairment.
Baseline, 6 months, 12 months, 18 months
Falls during followup period
Time Frame: Daily tracking from 12 months (trial completion) to end of 6-month followup (18 months)
The number of self-reported falls during the 6-month ifollowup period (i.e., rate of falls).
Daily tracking from 12 months (trial completion) to end of 6-month followup (18 months)
Memory
Time Frame: Baseline, 6 months, 12 months, 18 months
Memory measured by the Rey Auditory Verbal Learning Test
Baseline, 6 months, 12 months, 18 months
Gait Speed
Time Frame: Baseline, 6 months, 12 months, 18 months
Walking speed in m/s measured over 4 meters (part of the Short Physical Performance Battery)
Baseline, 6 months, 12 months, 18 months
Muscle Strength
Time Frame: Baseline, 6 months, 12 months, 18 months
Dominant quadriceps strength and dominant hand grip strength.
Baseline, 6 months, 12 months, 18 months
Community Mobility
Time Frame: Baseline, 6 months, 12 months, 18 months
Life Space Questionnaire to measure community mobility
Baseline, 6 months, 12 months, 18 months
Functional Mobility
Time Frame: Baseline, 6 months, 12 months, 18 months
Timed Up and Go Test to measure functional mobility
Baseline, 6 months, 12 months, 18 months
Fear of Falling
Time Frame: Baseline, 6 months, 12 months, 18 months
Fear of falling as assessed by the Iconographical Falls Efficacy Scale (Icon-FES).
Baseline, 6 months, 12 months, 18 months
Health Resource Utilization (HRU)
Time Frame: Baseline, 3 months, 6 months, 9 months, 12 months, 18 months
Cost data will be collected every 3 months using the HRU questionnaire
Baseline, 3 months, 6 months, 9 months, 12 months, 18 months
Sleep Quality (Objective) - Optional
Time Frame: Baseline, 6 months, 12 months, 18 months
Sleep quality parameters will be measured using ActiGraph
Baseline, 6 months, 12 months, 18 months
Brain Function - Optional
Time Frame: Baseline, 6 months, 12 months
Brain function will be measured using functional near-infrared spectroscopy
Baseline, 6 months, 12 months
NIH Cognitive Toolbox
Time Frame: Baseline, 6 months, 12 months, 18 months
Cognitive function measured using the NIH Cognitive Toolbox: Dimensional Change Card Sort Test and Flanker Inhibitory Control and Attention Test
Baseline, 6 months, 12 months, 18 months
Processing speed
Time Frame: Baseline, 6 months, 12 months, 18 months
Processing speed measured by Digit Symbol Substitution Test
Baseline, 6 months, 12 months, 18 months
Fatigue
Time Frame: Baseline, 6 months, 12 months, 18 months
The 9-item Fatigue Severity Scale will be used to assess how fatigue interferes with certain activities and its severity.
Baseline, 6 months, 12 months, 18 months
Quality of Life
Time Frame: Baseline, 3 months, 6 months, 9 months, 12 months, 18 months
The EuroQol EQ-5 Domain (5D)-5 Level (5L) (EQ-5D-5L) and the EuroQol Visual Analogue Scale (EQ-VAS) will assess quality of life
Baseline, 3 months, 6 months, 9 months, 12 months, 18 months
Physical Frailty
Time Frame: Baseline, 6 months, 12 months, 18 months
The Short Physical Performance Battery (physical performance battery out of 12 points (max. performance) and the Fried Frailty Phenotype (scores range from 0-5 where 0 is characterized as non-frail, 1-2 as pre-frail and >=3 as frail)
Baseline, 6 months, 12 months, 18 months
Physical Activity
Time Frame: Baseline, 6 months, 12 months, 18 months
The Physical Activity Scale for the Elderly (PASE) will be used to measure physical activity levels. PASE is a 12-item scale.
Baseline, 6 months, 12 months, 18 months
Mood
Time Frame: Baseline, 6 months, 12 months, 18 months
15-item Geriatric Depression Scale (GDS) will be used to assess depressive symptoms. GDS score of >=11/15 is suggestive of severe depression
Baseline, 6 months, 12 months, 18 months
Fall Risk
Time Frame: Baseline, 6 months, 12 months, 18 months
Fall risk is assessed by the Physiological Profile Assessment (PPA). A PPA z-score of 0-1 is indicative of mild fall risk, 1-2 indicates moderate risk, 2-3 indicates high risk, and > 3 indicates marked risk
Baseline, 6 months, 12 months, 18 months
Frailty Index
Time Frame: Baseline, 6 months, 12 months, 18 months
A frailty index will be calculated based on an accumulation of deficits across multiple domains and constructed using our primary and secondary outcome measures.
Baseline, 6 months, 12 months, 18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Teresa Liu-Ambrose, PhD, University of British Columbia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 15, 2025

Primary Completion (Estimated)

May 1, 2029

Study Completion (Estimated)

December 31, 2029

Study Registration Dates

First Submitted

February 17, 2025

First Submitted That Met QC Criteria

February 25, 2025

First Posted (Actual)

March 3, 2025

Study Record Updates

Last Update Posted (Actual)

September 9, 2026

Last Update Submitted That Met QC Criteria

September 3, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe